KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Johnson & Johnson (JNJ) EBT Margin (2016 - 2025)

Johnson & Johnson (JNJ) has disclosed EBT Margin for 17 consecutive years, with 20.22% as the latest value for Q4 2025.

  • Quarterly EBT Margin rose 296.0% to 20.22% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 34.59% through Dec 2025, up 1580.0% year-over-year, with the annual reading at 34.59% for FY2025, 1580.0% up from the prior year.
  • EBT Margin hit 20.22% in Q4 2025 for Johnson & Johnson, down from 31.23% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 62.26% in Q1 2025 to a low of 6.16% in Q2 2023.
  • Historically, EBT Margin has averaged 23.44% across 5 years, with a median of 24.94% in 2022.
  • Biggest five-year swings in EBT Margin: tumbled -3238bps in 2023 and later surged 4489bps in 2025.
  • Year by year, EBT Margin stood at 16.49% in 2021, then soared by 57bps to 25.87% in 2022, then dropped by -13bps to 22.56% in 2023, then decreased by -23bps to 17.26% in 2024, then increased by 17bps to 20.22% in 2025.
  • Business Quant data shows EBT Margin for JNJ at 20.22% in Q4 2025, 31.23% in Q3 2025, and 27.34% in Q2 2025.